← All Sponsors
SPONSOR

Shanghai AbelZeta Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Multiple Myeloma
NCT05521802 Phase 1, Phase 2
Recruiting

A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma
China View Trial →